(Q43912397)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135492%20AND%20SRC:MED&resulttype=core&format=json

cost-effectiveness analysis

19 January 2020

main subject

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

5

W J Edmunds

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

A J van Hoek

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

N Gay

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

W Opstelten

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

English

0 references

publication date

9 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

1454-1467

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135492%20AND%20SRC:MED&resulttype=core&format=json

Modelling the impact of immunization on the epidemiology of varicella zoster virus

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

A study of shingles and the development of postherpetic neuralgia in East London

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

The burden of Herpes Zoster: a prospective population based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Pain and its persistence in herpes zoster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Natural history of pain following herpes zoster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Acute Pain in Herpes Zoster and Its Impact on Health-Related Quality of Life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Herpes zoster and postherpetic neuralgia in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Current management of herpes zoster: the European view.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Recommendations for the Management of Herpes Zoster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Aging, immunity, and the varicella-zoster virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Phenotypic and functional characterization of ex vivo T cell responses to the live attenuated herpes zoster vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Vaccination against Herpes Zoster and Postherpetic Neuralgia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Assessing health needs in primary care. Morbidity study from general practice provides another source of information

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Predicting and preventing post-herpetic neuralgia: are current risk factors useful in clinical practice?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Herpes zoster and zosteriform herpes simplex virus infections in immunocompetent adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Routine detection of herpes simplex virus and varicella zoster virus by polymerase chain reaction reveals that initial herpes zoster is frequently misdiagnosed as herpes simplex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Clinical diagnosis of herpes zoster in family practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: Adaptation of the brief pain inventory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Brivudin compared with famciclovir in the treatment of herpes zoster: effects in acute disease and chronic pain in immunocompetent patients. A randomized, double-blind, multinational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine Introduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Cost-effectiveness of herpes zoster vaccine: flawed assumptions regarding efficacy against postherpetic neuralgia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

An analysis of infection control of varicella-zoster virus infections in Addenbrooke's Hospital Cambridge over a 5-year period, 1987-92.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Variations in population health status: results from a United Kingdom national questionnaire survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Varicella vaccination in England and Wales: cost-utility analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Gender difference in the incidence of shingles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

The PINE study: rationale and design of a randomised comparison of epidural injection of local anaesthetics and steroids versus care-as-usual to prevent postherpetic neuralgia in the elderly [ISRCTN32866390]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Lack of effect of acyclovir on postherpetic neuralgia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

The change in zoster-associated pain treated with oral valaciclovir in immunocompetent patients with acute herpes zoster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Valuing outcomes in health care: a comparison of willingness to pay and quality-adjusted life-years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

The burden of neuropathic pain: results from a cross-sectional survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.024

10.1016/J.VACCINE.2008.12.024

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference